Filana Therapeutics Inc (FLNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access FLNA quarterly Balance Sheets →
This page allows investors to track Filana Therapeutics Inc's balance sheet development across multiple reporting periods.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent95.50
Cash & Short-term Investments95.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.21
Total Current Assets97.71
Equipment/Property/Plant Net20.65
Intangible Assets0.00
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets118.36
Liabilities
Accounts Payable and Other Accrued Liabilities, Current41.65
Employee-related Liabilities, Current AC1.63
Other Liabilities, Current0.20
Total Current Liabilities43.83
Total Long-term Debt0.00
Other liabilities, Noncurrent0.12
OperatingLeaseLiabilityNoncurrent-
Accrued Development Expense Current0.36
Total Liabilities43.95
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock570.44
Retained Earnings / Accumulated Deficit-496.08
Other Equity0.00
Common Stockholder's Equity74.40
Total Stockholder's Equity74.40
Liabilities & Stockholder's Equity118.36
4 historic quarters locked

Sign in to unlock the full Filana Therapeutics Inc balance sheet history.

About Filana Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-26-007962

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License